The non-HDL-C/HDL-C ratio is a strong and independent predictor of the no-reflow phenomenon in patients with ST-elevation myocardial infarction

References

• Keeley EC, Boura JA, Grines CL. Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials. Lancet. 2003;361(9351):13–20. doi: 10.1016/S0140-6736(03)12113-7.
   PubMed Web of Science ®Google Scholar
• Fajar JK, Heriansyah T, Rohman MS. The predictors of no reflow phenomenon after percutaneous coronary intervention in patients with ST elevation myocardial infarction: a meta-analysis. Indian Heart J. 2018;70 Suppl 3(Suppl 3):S406–S418. doi: 10.1016/j.ihj.2018.01.032.
   PubMedGoogle Scholar
• Butler MJ, Chan W, Taylor AJ, et al. Management of the no-reflow phenomenon. Pharmacol Ther. 2011;132(1):72–85. doi: 10.1016/j.pharmthera.2011.05.010.
   PubMed Web of Science ®Google Scholar
• Galasso G, Schiekofer S, D'Anna C, et al. No-reflow phenomenon: pathophysiology, diagnosis, prevention, and treatment. A review of the current literature and future perspectives. Angiology. 2014;65(3):180–189. doi: 10.1177/0003319712474336.
   PubMed Web of Science ®Google Scholar
• Authors/Task Force Members; ESC Committee for Practice Guidelines (CPG); ESC National Cardiac Societies. 2019 ESC/EAS guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk. Atherosclerosis. 2019;290:140–205.
   PubMed Web of Science ®Google Scholar
• Lin D, Qi Y, Huang C, et al. Associations of lipid parameters with insulin resistance and diabetes: a population-based study. Clin Nutr. 2018;37(4):1423–1429. doi: 10.1016/j.clnu.2017.06.018.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Wu NQ, Li S, et al. Non-HDL-C is a better predictor for the severity of coronary atherosclerosis compared with LDL-C. Heart Lung Circ. 2016;25(10):975–981. doi: 10.1016/j.hlc.2016.04.025.
   PubMed Web of Science ®Google Scholar
• Wang A, Li Y, Zhou L, et al. Non-HDL-C/HDL-C ratio is associated with carotid plaque stability in general population: a cross-sectional study. Front Neurol. 2022;13:875134. doi: 10.3389/fneur.2022.875134.
   PubMed Web of Science ®Google Scholar
• Masson W, Epstein T, Huerín M, et al. Association between non-HDL-C/HDL-C ratio and carotid atherosclerosis in postmenopausal Middle-aged women. Climacteric. 2019;22(5):518–522. doi: 10.1080/13697137.2019.1631787.
   PubMed Web of Science ®Google Scholar
• Mao Q, Zhao J, Zhao X. Association of non-HDL-C-to-HDL-C ratio with coronary lesions and its prognostic performance in first-onset NSTEMI. Biomark Med. 2023;17(1):29–39.
   PubMed Web of Science ®Google Scholar
• Zhao W, Gong W, Wu N, et al. Association of lipid profiles and the ratios with arterial stiffness in Middle-aged and elderly Chinese. Lipids Health Dis. 2014;13(1):37. doi: 10.1186/1476-511X-13-37.
   PubMed Web of Science ®Google Scholar
• You J, Wang Z, Lu G, et al. Association between the non-high-Density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio and the risk of coronary artery disease. Biomed Res Int. 2020;2020:7146028–7146029. doi: 10.1155/2020/7146028.
   PubMed Web of Science ®Google Scholar
• Zhou B, Ren H, Zhou X, et al. Associations of iron status with apolipoproteins and lipid ratios: a cross-sectional study from the China health and nutrition survey. Lipids Health Dis. 2020;19(1):140. doi: 10.1186/s12944-020-01312-9.
   PubMed Web of Science ®Google Scholar
• Płaczkowska S, Sołkiewicz K, Bednarz-Misa I, et al. Atherogenic plasma ındex or non-high-density lipoproteins as markers best reflecting age-related high concentrations of small dense low-density lipoproteins. Int J Mol Sci. 2022;23(9):5089. doi: 10.3390/ijms23095089.
   PubMed Web of Science ®Google Scholar
• Süleymanoğlu M, Rencüzoğulları İ, Karabağ Y, et al. The relationship between atherogenic index of plasma and no-reflow in patients with acute ST-segment elevation myocardial infarction who underwent primary percutaneous coronary intervention. Int J Cardiovasc Imaging. 2020;36(5):789–796. doi: 10.1007/s10554-019-01766-8.
   PubMed Web of Science ®Google Scholar
• Sniderman AD, Williams K, Contois JH, et al. A meta-analysis of low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol, and apolipoprotein B as markers of cardiovascular risk. Circ Cardiovasc Qual Outcomes. 2011;4(3):337–345. doi: 10.1161/CIRCOUTCOMES.110.959247.
   PubMed Web of Science ®Google Scholar
• Verbeek R, Hovingh GK, Boekholdt SM. Non-high-density lipoprotein cholesterol: current status as cardiovascular marker. Curr Opin Lipidol. 2015;26(6):502–510. doi: 10.1097/MOL.0000000000000237.
   PubMed Web of Science ®Google Scholar
• van Deventer HE, Miller WG, Myers GL, et al. Non-HDL cholesterol shows improved accuracy for cardiovascular risk score classification compared to direct or calculated LDL cholesterol in a dyslipidemic population. Clin Chem. 2011;57(3):490–501. doi: 10.1373/clinchem.2010.154773.
   PubMed Web of Science ®Google Scholar
• Campbell S, Genest J. HDL-C: clinical equipoise and vascular endothelial function. Expert Rev Cardiovasc Ther. 2013;11(3):343–353. doi: 10.1586/erc.13.17.
   PubMedGoogle Scholar
• van der Stoep M, Korporaal SJ, Van Eck M. High-density lipoprotein as a modulator of platelet and coagulation responses. Cardiovasc Res. 2014;103(3):362–371. doi: 10.1093/cvr/cvu137.
   PubMed Web of Science ®Google Scholar
• Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of The national cholesterol education program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol In adults (adult treatment panel III). JAMA. 2001;285(19):2486–2497. doi: 10.1001/jama.285.19.2486.
   PubMed Web of Science ®Google Scholar
• Ibanez B, James S, Agewall S,, et al. 2017 ESC guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: the task force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European society of cardiology (ESC). Eur Heart J. 2018;39(2):119–177. doi: 10.1093/eurheartj/ehx393.
   PubMed Web of Science ®Google Scholar
• TIMI Study Group. The thrombolysis in myocardial ınfarction (TIMI) trial. Phase I findings. N Engl J Med. 1985;312(14):932–936.
   PubMed Web of Science ®Google Scholar
• Niccoli G, Kharbanda RK, Crea F, et al. No-reflow: again prevention is better than treatment. Eur Heart J. 2010;31(20):2449–2455. doi: 10.1093/eurheartj/ehq299.
   PubMed Web of Science ®Google Scholar
• Vrints CJ. Pathophysiology of the no-reflow phenomenon. Acute Card Care. 2009;11(2):69–76. doi: 10.1080/17482940902978061.
   PubMedGoogle Scholar
• Zhou Z, Ong KL, Whelton SP, et al. Impact of blood lipids on 10-year cardiovascular risk in ındividuals Without dyslipidemia and with low risk factor burden. Mayo Clin Proc. 2022;97(10):1883–1893. doi: 10.1016/j.mayocp.2022.03.025.
   PubMed Web of Science ®Google Scholar
• Srikanth S, Ambrose JA. Pathophysiology of coronary thrombus formation and adverse consequences of thrombus during PCI. Curr Cardiol Rev. 2012;8(3):168–176. doi: 10.2174/157340312803217247.
   PubMedGoogle Scholar
• Martin M, Gaete L, Tetzlaff W, et al. Vascular inflammation and impaired reverse cholesterol transport and lipid metabolism in obese children and adolescents. Nutr Metab Cardiovasc Dis. 2022;32(1):258–268. doi: 10.1016/j.numecd.2021.09.025.
   PubMed Web of Science ®Google Scholar
• Kathariya G, Aggarwal J, Garg P, et al. Is evaluation of non-HDL-C better than calculated LDL-C in CAD patients? MMIMSR experiences. Indian Heart J. 2020;72(3):189–191. doi: 10.1016/j.ihj.2020.05.008.
   PubMedGoogle Scholar
• Zhao SR, Huang R, Liu F, et al. Study on correlation between type 2 diabetes and no-reflow after PCI. Dis Markers. 2022;2022:7319277–7319277. doi: 10.1155/2022/7319277.
   PubMed Web of Science ®Google Scholar
• Wang CY, Chang TC. Non-HDL cholesterol level is reliable to be an early predictor for vascular inflammation in type 2 diabetes mellitus. J Clin Endocrinol Metab. 2004;89(9):4762–4767. doi: 10.1210/jc.2004-0820.
   PubMed Web of Science ®Google Scholar
• Toth PP, Simko RJ, Palli SR, et al. The impact of serum lipids on risk for microangiopathy in patients with type 2 diabetes mellitus. Cardiovasc Diabetol. 2012;11(1):109. doi: 10.1186/1475-2840-11-109.
   PubMed Web of Science ®Google Scholar
• Prado MM, Carrizo T, Abregú AV, et al. Non-HDL-cholesterol and C-reactive protein in children and adolescents with type 1 diabetes. J Pediatr Endocrinol Metab. 2017;30(3):285–288.
   PubMed Web of Science ®Google Scholar
• Poledne R, Kralova Lesna I, Kralova A, et al. The relationship between non-HDL cholesterol and macrophage phenotypes in human adipose tissue. J Lipid Res. 2016;57(10):1899–1905. doi: 10.1194/jlr.P068015.
   PubMed Web of Science ®Google Scholar
• Karasek D, Vaverkova H, Cibickova L, et al. Apolipoprotein B vs non-high-density lipoprotein cholesterol: association with endothelial hemostatic markers and carotid intima-media thickness. J Clin Lipidol. 2017;11(2):442–449. doi: 10.1016/j.jacl.2017.01.020.
   PubMed Web of Science ®Google Scholar
• Han M, Li Q, Qie R, et al. Association of non-HDL-C/HDL-C ratio and its dynamic changes with incident type 2 diabetes mellitus: the rural chinese cohort study. J Diabetes Complications. 2020;34(12):107712. doi: 10.1016/j.jdiacomp.2020.107712.
   PubMed Web of Science ®Google Scholar
• Zhang N, Hu X, Zhang Q, et al. Non-high-density lipoprotein cholesterol: high-density lipoprotein cholesterol ratio is an independent risk factor for diabetes mellitus: results from a population-based cohort study. J Diabetes. 2018;10(9):708–714. doi: 10.1111/1753-0407.12650.
   PubMed Web of Science ®Google Scholar
• Byun AR, Lee SW, Lee HS, et al. What is the most appropriate lipid profile ratio predictor for insulin resistance in each sex? A cross-sectional study in Korean populations (The Fifth Korea National Health and Nutrition examination survey). Diabetol Metab Syndr. 2015;7(1):59. doi: 10.1186/s13098-015-0051-2.
   PubMed Web of Science ®Google Scholar
• Yang H, Young D, Gao J, et al. Are blood lipids associated with microvascular complications among type 2 diabetes mellitus patients? A cross-sectional study in Shanghai, China. Lipids Health Dis. 2019;18(1):18. doi: 10.1186/s12944-019-0970-2.
   PubMed Web of Science ®Google Scholar
• Odegaard JI, Chawla A. Pleiotropic actions of insulin resistance and inflammation in metabolic homeostasis. Science. 2013;339(6116):172–177. doi: 10.1126/science.1230721.
   PubMed Web of Science ®Google Scholar
• Celik T, Iyisoy A. Impact of metabolic syndrome on no-reflow after primary percutaneous coronary intervention in patients with acute ST elevation myocardial infarction. Nutr Metab Cardiovasc Dis. 2008;18(5):e21-2–e22. doi: 10.1016/j.numecd.2007.12.007.
   PubMedGoogle Scholar
• Tanaka A, Imanishi T, Kitabata H, et al. Lipid-rich plaque and myocardial perfusion after successful stenting in patients with non-ST-segment elevation acute coronary syndrome: an optical coherence tomography study. Eur Heart J. 2009;30(11):1348–1355. doi: 10.1093/eurheartj/ehp122.
   PubMed Web of Science ®Google Scholar
• Virani SS, Catellier DJ, Pompeii LA, et al. Relation of cholesterol and lipoprotein parameters with carotid artery plaque characteristics: the atherosclerosis risk in communities (ARIC) carotid MRI study. Atherosclerosis. 2011;219(2):596–602. doi: 10.1016/j.atherosclerosis.2011.08.001.
   PubMed Web of Science ®Google Scholar
• Gao G, Xu H, Zhang D, et al. The predictive value of baseline target lesion SYNTAX score for no-reflow during urgent percutaneous coronary ıntervention in acute myocardial ınfarction. J Interv Cardiol. 2021;2021:9987265–9987269. doi: 10.1155/2021/9987265.
   PubMedGoogle Scholar
• Li Y, Chen X, Li S, et al. Non-high-density lipoprotein cholesterol/high-density lipoprotein cholesterol ratio serve as a predictor for coronary collateral circulation in chronic total occlusive patients. BMC Cardiovasc Disord. 2021;21(1):311. doi: 10.1186/s12872-021-02129-9.
   PubMed Web of Science ®Google Scholar
• Dall’Ara G, Testa L, Tumscitz C, et al. No-reflow complicating chronic total occlusion coronary revascularization. J Invasive Cardiol. 2020;32(2):58–63.
   PubMed Web of Science ®Google Scholar
• Zachura M, Sadowski M, Kurzawski J, et al. Heterogeneity of the no-reflow group after primary percutaneous coronary ıntervention due to ST-segment elevation myocardial Infarction - Are there sex differences? Cardiovasc Revasc Med. 2022;37:97–101. doi: 10.1016/j.carrev.2021.06.014.
   PubMed Web of Science ®Google Scholar
• Iannuzzi A, Giallauria F, Gentile M, et al. Association between non-HDL-C/HDL-C ratio and carotid ıntima-media thickness in post-menopausal women. J Clin Med. 2021;11(1):78. doi: 10.3390/jcm11010078.
   PubMed Web of Science ®Google Scholar
• ; Di Angelantonio E, Sarwar N, Perry P, et al. Major lipids, apolipoproteins, and risk of vascular disease. JAMA. 2009;302(18):1993–2000. doi: 10.1001/jama.2009.1619.
   PubMed Web of Science ®Google Scholar